Daily BriefsECM

Daily Brief ECM: WuXi XDC IPO: Valuation Insights and more

In today’s briefing:

  • WuXi XDC IPO: Valuation Insights
  • Sichuan Baicha Baidao Pre-IPO – The Negatives – Growth Is Unsustainable
  • Jyoti CNC IPO- Forensic Analysis
  • Pre-IPO Pu’er Lancang Ancient Tea (PHIP Updates) – Lack of Product Standardization Is the Pain Point


WuXi XDC IPO: Valuation Insights

By Arun George

  • WuXi XDC Cayman (1877628D HK), a leading contract research, development and manufacturing organization (CRDMO), has launched an HKEx IPO to raise up to US$470 million.
  • We previously discussed the IPO in WuXi XDC IPO: The Bull Case and WuXi XDC IPO: The Bear Case.
  • Blue-Chip cornerstones will purchase US$300 million of the offer. Our base-case DCF valuation is HK$22.84 per share, 12.8% above the midpoint of the IPO price range.

Sichuan Baicha Baidao Pre-IPO – The Negatives – Growth Is Unsustainable

By Sumeet Singh

  • Sichuan Baicha Baidao Industrial (SBBI) is looking to raise up to US$300m in its upcoming HK IPO.
  • SBBI sells new-style tea drinks through its ChaPanda stores. According to F&S, SBBI ranked third in China’s new-style tea shop market with a market share of 6.6%.
  • In this note, we talk about the not so positive aspects of the deal.

Jyoti CNC IPO- Forensic Analysis

By Nitin Mangal

  • Jyoti CNC Automation (0907734D IN) plans to come up with ~INR 10 bn IPO
  • JCAL is an established player in manufacturing of metal cutting CNC machines, mostly in 5-Axis category. It has 8% market share in India and is 12th largest global player.
  • Even though JCAL has bright order book visibility, it remains unprofitable, largely because of concerns with subsidiaries.

Pre-IPO Pu’er Lancang Ancient Tea (PHIP Updates) – Lack of Product Standardization Is the Pain Point

By Xinyao (Criss) Wang

  • Traditional tea companies are rarely seen in China’s secondary market. The most significant issue in the domestic tea industry is product standardization, leading to obvious bottlenecks in future revenue/profit scale. 
  • Despite increasing investment in sales/marketing, financial results of Lancang haven’t shown much improvement. Sales of 1966 products would continue to be under pressure due to weak demand during economic downturn.
  • Lancang’s financial performance is unsatisfactory, with declining revenue growth and profit margin. We are not optimistic about the Company’s prospects. Valuation should be lower than Nayuki Holdings (2150 HK).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars